clsi recommended atcc 25922 (ATCC)
Structured Review

Clsi Recommended Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5425 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recommendations/Klebsiella+quasipneumoniae+Brisse+et+al/pmc13055255-72-0-1
Average 99 stars, based on 5425 article reviews
Images
1) Product Images from "Phenotypic and genomic characterization of NDM-producing Escherichia coli colonizing the pediatric gut in Shenzhen, China"
Article Title: Phenotypic and genomic characterization of NDM-producing Escherichia coli colonizing the pediatric gut in Shenzhen, China
Journal: Microbiology Spectrum
doi: 10.1128/spectrum.03329-25
Figure Legend Snippet: The LDH activity in NCM460 infected by different strains. An unpaired two-sided Student’s t -test was performed for LDH production (mean ± standard). All isolates showed significantly higher cytotoxicity than the reference strain E. coli ATCC 25922 (low cytotoxicity, unpaired two-sided Student’s t -test, * P < 0.05).
Techniques Used: Activity Assay, Infection
Related Articles
Bacteria:Article Title: Biogenic silver nanoparticles from Salvia hypargeia: In vitro antioxidant, antibacterial, antibiofilm, and antiproliferative properties. Article Snippet: Silver nanoparticles (AgNPs) were synthesised from water extracts of Salvia hypargeia.. The synthesised AgNPs were characterised by UV-Vis spectroscopy, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), energy dispersive X-ray spectroscopy (EDX), transmission electron microscopy (TEM) and zeta potential analysis.. The antioxidant (DPPḢ, ABTṠ, FRAP), antibacterial (Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Klebsiella pneumonia), antibiofilm and antiproliferative activities (L929, Caco-2, and A549) of the water extract and synthesised AgNPs from S. hypargeia were investigated. Negative Control:Article Title: Outer Membrane Vesicles Derived From Klebsiella pneumoniae Aggravate Primary Sclerosing Cholangitis in Mdr2 −/− Mice and IL‐17A‐Stimulated Cholangiocyte Organoids Article Snippet: .. To test this, we employed Gene Expression:Article Title: An integrated molecular, phenotypic, and adaptive analysis of polymyxin resistance in KPC-producing Klebsiella pneumoniae Article Snippet: .. Relative gene expression was calculated using the comparative Ct (2^-ΔΔCt) method (Livak and Schmittgen ), with expression normalized to the Expressing:Article Title: An integrated molecular, phenotypic, and adaptive analysis of polymyxin resistance in KPC-producing Klebsiella pneumoniae Article Snippet: .. Relative gene expression was calculated using the comparative Ct (2^-ΔΔCt) method (Livak and Schmittgen ), with expression normalized to the Incubation:Article Title: In vitro activity of oral antibiotics against extensively drug-resistant Shigella isolates: a pharmacokinetic/pharmacodynamic perspective on the intracellular pathogenesis paradigm Article Snippet: For candidate oral agents, MICs were determined as follows: amoxicillin–clavulanate (2 : 1 ratio) and cefpodoxime–clavulanate (fixed 4 μg ml −1 clavulanate): BMD in cation-adjusted Mueller–Hinton broth II (Thermo Fisher Scientific) using 96-well panels, MIC ranges 0.016–256 mg l −1 ; fosfomycin (trometamol): BMD supplemented with glucose-6-phosphate (50 μg ml −1 , essential cofactor for fosfomycin uptake), MIC ranges 0.016–256 mg l −1 ; faropenem: BMD as above, MIC ranges 0.016–256 mg l −1 ; mecillinam: agar dilution using Mueller–Hinton agar (Thermo Fisher Scientific) with 2% NaCl, MIC ranges 0.016–256 mg l −1 (agar dilution preferred for mecillinam per CLSI recommendations). .. All testing plates were incubated aerobically at 35±2 °C for 16–20 h. Quality control strains included Escherichia coli ATCC 25922 and QC/EQA/Proficiency:Article Title: In vitro activity of oral antibiotics against extensively drug-resistant Shigella isolates: a pharmacokinetic/pharmacodynamic perspective on the intracellular pathogenesis paradigm Article Snippet: For candidate oral agents, MICs were determined as follows: amoxicillin–clavulanate (2 : 1 ratio) and cefpodoxime–clavulanate (fixed 4 μg ml −1 clavulanate): BMD in cation-adjusted Mueller–Hinton broth II (Thermo Fisher Scientific) using 96-well panels, MIC ranges 0.016–256 mg l −1 ; fosfomycin (trometamol): BMD supplemented with glucose-6-phosphate (50 μg ml −1 , essential cofactor for fosfomycin uptake), MIC ranges 0.016–256 mg l −1 ; faropenem: BMD as above, MIC ranges 0.016–256 mg l −1 ; mecillinam: agar dilution using Mueller–Hinton agar (Thermo Fisher Scientific) with 2% NaCl, MIC ranges 0.016–256 mg l −1 (agar dilution preferred for mecillinam per CLSI recommendations). .. All testing plates were incubated aerobically at 35±2 °C for 16–20 h. Quality control strains included Escherichia coli ATCC 25922 and other:Article Title: Siamese banana peel-mediated synthesis of silver nanoparticles and their broad-spectrum antibacterial activity Article Snippet: |
